Development of drugs targeting hypoxia‐inducible factor against tumor cells with VHL mutation: Story of 127 years

por Takamori, Hajime, Yamasaki, Toshinari, Kitadai, Rui, Minamishima, Yoji Andrew, Nakamura, Eijiro
Publicado 2023

TFEB ‐translocated and ‐amplified renal cell carcinoma with VEGFA co‐amplification: A case of long‐term control by multimodal therapy including a vascular endothelial growth fact...

por Takamori, Hajime, Maeshima, Akiko Miyagi, Kato, Ikuma, Baba, Masaya, Nakamura, Eijiro, Matsui, Yoshiyuki
Publicado 2023

Detection of von Hippel‐Lindau gene mutation in circulating cell‐free DNA for clear cell renal cell carcinoma

por Sumiyoshi, Takayuki, Yamasaki, Toshinari, Takeda, Masashi, Mizuno, Kei, Utsunomiya, Noriaki, Sakamoto, Hiromasa, Nakamura, Eijiro, Ogawa, Osamu, Akamatsu, Shusuke
Publicado 2021

Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin

por Kandori, Shuya, Kojima, Takahiro, Matsuoka, Taeko, Yoshino, Takayuki, Sugiyama, Aiko, Nakamura, Eijiro, Shimazui, Toru, Funakoshi, Yuji, Kanaho, Yasunori, Nishiyama, Hiroyuki
Publicado 2018

Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

por Shibasaki, Noboru, Yamasaki, Toshinari, Kanno, Toru, Arakaki, Ryuichiro, Sakamoto, Hiromasa, Utsunomiya, Noriaki, Inoue, Takahiro, Tsuruyama, Tatsuaki, Nakamura, Eijiro, Ogawa, Osamu, Kamba, Tomomi
Publicado 2015

Contribution of Chromosome 9p21‐22 Deletion to the Progression of Human Renal Cell Carcinoma

por Kinoshita, Hidefumi, Yamada, Hitoshi, Ogawa, Osamu, Kakehi, Yoshiyuki, Osaka, Mitsuhiko, Nakamura, Eijiro, Mishina, Mutsuki, Habuchi, Tomonori, Takahashi, Rei, Sugiyama, Taketoshi, Yoshida, Osamu
Publicado 1995

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma

por Arakaki, Ryuichiro, Yamasaki, Toshinari, Kanno, Toru, Shibasaki, Noboru, Sakamoto, Hiromasa, Utsunomiya, Noriaki, Sumiyoshi, Takayuki, Shibuya, Shinsuke, Tsuruyama, Tatsuaki, Nakamura, Eijiro, Ogawa, Osamu, Kamba, Tomomi
Publicado 2016

The Transcription Factor Sp3 Regulates the Expression of a Metastasis-Related Marker of Sarcoma, Actin Filament-Associated Protein 1-Like 1 (AFAP1L1)

por Kajita, Yoichiro, Kato, Tomohisa, Tamaki, Sakura, Furu, Moritoshi, Takahashi, Ryo, Nagayama, Satoshi, Aoyama, Tomoki, Nishiyama, Hiroyuki, Nakamura, Eijiro, Katagiri, Toyomasa, Nakamura, Yusuke, Ogawa, Osamu, Toguchida, Junya
Publicado 2013

Functional and genomic characterization of patient‐derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma

por Sakamoto, Hiromasa, Yamasaki, Toshinari, Sumiyoshi, Takayuki, Takeda, Masashi, Shibasaki, Noboru, Utsunomiya, Noriaki, Arakaki, Ryuichiro, Akamatsu, Shusuke, Kobayashi, Takashi, Inoue, Takahiro, Kamba, Tomomi, Nakamura, Eijiro, Ogawa, Osamu
Publicado 2020

Osteoblast‐derived extracellular vesicles exert osteoblastic and tumor‐suppressive functions via SERPINA3 and LCN2 in prostate cancer

por Ito, Kagenori, Yamamoto, Tomofumi, Hayashi, Yusuke, Sato, Shun, Nakayama, Jun, Urabe, Fumihiko, Shimasaki, Takeo, Nakamura, Eijiro, Matui, Yoshiyuki, Fujimoto, Hiroyuki, Kimura, Takahiro, Egawa, Shin, Ochiya, Takahiro, Yamamoto, Yusuke
Publicado 2023

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation

por Taki, Mana, Abiko, Kaoru, Baba, Tsukasa, Hamanishi, Junzo, Yamaguchi, Ken, Murakami, Ryusuke, Yamanoi, Koji, Horikawa, Naoki, Hosoe, Yuko, Nakamura, Eijiro, Sugiyama, Aiko, Mandai, Masaki, Konishi, Ikuo, Matsumura, Noriomi
Publicado 2018

Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing

por Yamamoto, Yoshihiro, Kanai, Masashi, Kou, Tadayuki, Sugiyama, Aiko, Nakamura, Eijiro, Miyake, Hidehiko, Yamada, Takahiro, Nishigaki, Masakazu, Kondo, Tomohiro, Murakami, Hiromi, Torishima, Masako, Matsumoto, Shigemi, Kosugi, Shinji, Muto, Manabu
Publicado 2019

HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function

por Mitani, Yosuke, Ohashi, Shinya, Kikuchi, Osamu, Nakai, Yukie, Ida, Tomomi, Mizumoto, Ayaka, Yamamoto, Yoshihiro, Saito, Tomoki, Kataoka, Shigeki, Matsubara, Junichi, Yamada, Atsushi, Kanai, Masashi, Matsumoto, Shigemi, Sakai, Hiroaki, Yoshikawa, Kiyotsugu, Nakamura, Eijiro, Muto, Manabu
Publicado 2022

Clinical sequencing using a next‐generation sequencing‐based multiplex gene assay in patients with advanced solid tumors

por Kou, Tadayuki, Kanai, Masashi, Yamamoto, Yoshihiro, Kamada, Mayumi, Nakatsui, Masahiko, Sakuma, Tomohiro, Mochizuki, Hiroaki, Hiroshima, Akinori, Sugiyama, Aiko, Nakamura, Eijiro, Miyake, Hidehiko, Minamiguchi, Sachiko, Takaori, Kyoichi, Matsumoto, Shigemi, Haga, Hironori, Seno, Hiroshi, Kosugi, Shinji, Okuno, Yasushi, Muto, Manabu
Publicado 2017

Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma

por Yonamine, Masato, Wasano, Koichiro, Aita, Yuichi, Sugasawa, Takehito, Takahashi, Katsutoshi, Kawakami, Yasushi, Shimano, Hitoshi, Nishiyama, Hiroyuki, Hara, Hisato, Naruse, Mitsuhide, Okamoto, Takahiro, Matsuda, Tadashi, Kosugi, Shinji, Horiguchi, Kazuhiko, Tanabe, Akiyo, Watanabe, Atsushi, Kimura, Noriko, Nakamura, Eijiro, Sakurai, Akihiro, Shiga, Kiyoto, Takekoshi, Kazuhiro
Publicado 2021